Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

The chief executive of Novartis on Wednesday defended the company’s decision to delay telling the Food and Drug Administration about manipulated data involving its $2.1 million gene therapy treatment, saying that it “thoroughly, aggressively” investigated the issue and that patient safety was never threatened. Vas Narasimhan, the chief executive, also indicated in a call with…

Would You Like to Hang Out Here?

Private social clubs would seem to be a perfect match for Los Angeles, where the best parties usually happen behind closed doors. But until recently, the main game in town was the Jonathan Club, which was founded in 1895 and barely registered among the young, dewier set. Everything changed in 2010, when Soho House opened…